Clinical trials are ongoing in most parts of the country for all stages of non-small cell lung cancer. Treatment choices can be discussed with a doctor
LUNG CANCER: TREATMENT OF NON-SMALL CELL LUNG CANCER IN THE ELDERLY Authored by: Bryan J. Schneider, M.D. and Gregory P. Kalemkerian, M.D. Division of Hematology/Oncology, Department of Internal Medicine
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer This study is currently recruiting patients. Verified by National Institutes of Health Clinical Center (CC) August 29, 2005
Non-Small Cell Lung Cancer Lung cancer is ... for third-line treatment. Survival Rates 3 , 4 The average age-adjusted 5-year relative survival rate for Americans with non-small cell lung cancer is 16 ...
Learn about non-small cell lung cancer, explore treatment options, and find resources for additional help. Tarceva (erlotinib) is indicated for the treatment of patients with locally advanced or ...